Results
2311
All the companies in the healthcare sector, including healthcare provider and equipment, healthcare tech, pharmaceuticals, biotech and life sciences.
2,311 companies
CannLabs
Market Cap: US$94.2k
Provides cannabis testing laboratory services in the United States.
CANL
US$0.0001
7D
0%
1Y
9,900.0%
Drug Free Solution
Market Cap: US$88.9k
A lifestyle company, delivers proprietary emotional wellness technology, known as Living Breath Process.
DSOL
US$0.0002
7D
0%
1Y
n/a
SK3 Group
Market Cap: US$83.0k
Provides management advisory, licensing, and marketing services for medical marijuana collectives in California.
SKTO
US$0.000067
7D
0%
1Y
6,600.0%
BodyScan
Market Cap: US$81.9k
Offers medical imaging services that include GE-Imatron Electron Beam Tomography (EBT) scanning for coronary artery disease (CAD), lung diseases, tumors, and stones detection.
BDYS
US$0.0001
7D
0%
1Y
n/a
GB Sciences
Market Cap: US$81.4k
A plant-based research and biopharmaceutical drug development company.
GBLX
US$0.0002
7D
0%
1Y
-97.1%
MabCure
Market Cap: US$78.1k
MabCure Inc., a development stage company, engages in developing and commercializing its proprietary antibody technology for the early detection of cancer, and for the creation of specific therapeutics against cancer.
MBCI
US$0.0001
7D
0%
1Y
n/a
Global Health Clinics
Market Cap: CA$93.9k
Operates in the cannabis industry.
MJRX
CA$0.01
7D
0%
1Y
n/a
Blue Water Ventures International
Market Cap: US$60.6k
Through its subsidiary, Psycheceutical Inc., focuses on developing pharmaceutical products and technologies for mental health treatments.
BWVI
US$0.0002
7D
0%
1Y
-98.5%
Navidea Biopharmaceuticals
Market Cap: US$60.0k
A biopharmaceutical company, focuses on the development and commercialization of precision immunodiagnostic agents and immunotherapeutics.
NAVB
US$0.0006
7D
-14.3%
1Y
-98.3%
Affymax
Market Cap: US$59.6k
Does not have significant operations.
AFFY
US$0.0008
7D
0%
1Y
6.7%
Immunotech Laboratories
Market Cap: US$57.5k
Develops and commercializes proprietary proteins for use in treating human immunodeficiency virus (HIV), acquired immune deficiency syndrome (AIDS), hepatitis, and other immuno-related disorders.
IMMB
US$0.0001
7D
0%
1Y
n/a
Hero Technologies
Market Cap: US$56.4k
Operates as an early-stage cannabis company.
HENC
US$0.0001
7D
0%
1Y
-96.3%
Manhattan Scientifics
Market Cap: US$55.9k
A technology incubator, engages in the acquisition, development, and commercialization of life-enhancing technologies in the United States.
MHTX
US$0.0001
7D
0%
1Y
-90.0%
Globaltech Holdings
Market Cap: US$54.2k
Globaltech Holdings, Inc. holds and manages real and intellectual properties.
GLBH
US$0.0001
7D
0%
1Y
n/a
Medivolve
Market Cap: US$54.0k
A principal investment firm.
MEDV.F
US$0.002
7D
0%
1Y
-73.3%
Mera Pharmaceuticals
Market Cap: US$53.7k
Focuses on the development and commercialization of natural products from microalgae using its proprietary and large-scale photobioreactor technology.
MRPI
US$0.0001
7D
0%
1Y
n/a
G Medical Innovations Holdings
Market Cap: US$52.9k
An early commercial stage healthcare company, engages in the development of next generation mobile health and telemedicine solutions in Israel.
GMVD.F
US$0.0002
7D
0%
1Y
-98.6%
Veritas Farms
Market Cap: US$49.1k
Focuses on growing, producing, marketing, and distributing hemp oils and extracts containing phytocannabinoids.
VFRM
US$0.0003
7D
0%
1Y
-98.2%
Acro Biomedical
Market Cap: US$42.0k
Engages in the development and marketing of nutritional products.
ACBM
US$0.0007
7D
0%
1Y
n/a
Sangui Biotech International
Market Cap: US$42.0k
Through its subsidiaries, engages in the manufacturing and sales of wound treatment and cosmetic products.
SGBI
US$0.0002
7D
0%
1Y
n/a
Marizyme
Market Cap: US$39.5k
A multi-technology biomedical company, develops and commercializes medical technologies to enhances patients health.
MRZM
US$0.0003
7D
0%
1Y
-99.5%
Medican Enterprises
Market Cap: US$38.9k
A bio-pharmaceutical company, focuses on pursuing business opportunities in the medical and recreational marijuana sector.
MDCN
US$0.000001
7D
0%
1Y
0%
Genesis Healthcare
Market Cap: US$35.7k
Owns and operates skilled nursing facilities and assisted/senior living facilities in the United States.
GENN
US$0.0002
7D
0%
1Y
-84.6%
NDT Pharmaceuticals
Market Cap: US$33.9k
A biotechnology company, focuses on developing various therapies for severe neurological disorders associated with traumatic brain Injury.
NDTP
US$0.071
7D
-21.5%
1Y
-69.1%
Holdco Nuvo Group D.G
Market Cap: US$32.6k
Engages in the research, development, and marketing of medical devices for pregnancy monitoring in Israel, the United States, and internationally.
NUVO.Q
US$0.0009
7D
0%
1Y
-100.0%
Medical Imaging
Market Cap: US$31.9k
Through its subsidiaries, provides medical diagnostic imaging services for patients, hospitals and clinics, workers’ compensation boards, and insurance companies in North America.
MEDD
US$0.0001
7D
0%
1Y
n/a
Bioasis Technologies
Market Cap: US$31.8k
A development stage biopharmaceutical company, engages in the research and development of products for the diagnosis and treatment of neurological diseases and disorders.
BIOA.F
US$0.0004
7D
0%
1Y
n/a
SOAFEE
Market Cap: US$31.0k
Provides artificial intelligence (AI) and information technology (IT) services, and enterprise AI software-as a-service (SaaS) solutions for enterprises.
SOFE
US$0.0011
7D
0%
1Y
-72.5%
Bud Genius
Market Cap: US$30.0k
Provides cannabis testing and profiling services.
RIGH
US$0.000001
7D
0%
1Y
0%
Advanced BioMedical Technologies
Market Cap: US$28.4k
Advanced Biomedical Technologies, Inc., a development stage company, designs, develops, manufactures, and markets biomaterial internal fixation devices.
ABMT
US$0.0004
7D
0%
1Y
-33.3%
In Veritas Medical Diagnostics
Market Cap: US$25.8k
A development stage company, engages in the research and development of medical devices with `near-patient' testing applications.
IVME
US$0.0003
7D
0%
1Y
n/a
Curative Biosciences
Market Cap: US$25.8k
Focuses on developing and commercializing therapeutics using hemp-derived Cannabidiol.
CBDX
US$0.0001
7D
0%
1Y
n/a
Vaxxinity
Market Cap: US$25.3k
A biotechnology company, focuses on developing product candidates for human use in the fields of neurology, cardiovascular diseases, and coronaviruses in the United States.
VAXX
US$0.0002
7D
-99.6%
1Y
-99.6%
NovAccess Global
Market Cap: US$24.8k
A biopharmaceutical company, develops novel immunotherapies to treat brain tumor patients in the United States.
XSNX
US$0.0004
7D
0%
1Y
-94.3%
Life Stem Genetics
Market Cap: US$24.6k
A development stage company, focuses on establishing stem cell therapy based clinics worldwide.
LIFS
US$0.0001
7D
0%
1Y
-93.8%
Cannonau
Market Cap: US$24.2k
Provides cannabidiol based products.
CNNC
US$0.0001
7D
0%
1Y
-99.3%